NCT04303416View on ClinicalTrials.gov

Plasma Exchange With Albumin in AMN Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 9, 2020

Primary Completion Date

February 24, 2021

Study Completion Date

September 13, 2021

Conditions
AdrenomyeloneuropathyAdrenoleukodystrophy
Interventions
DRUG

Albumin solution

plasma exchange with albumin, one per week for one month, then one per month for 5 months

Trial Locations (1)

08908

Bellvitge University Hospital, L'Hospitalet de Llobregat

All Listed Sponsors
lead

Pujol, Aurora, M.D.

INDIV

NCT04303416 - Plasma Exchange With Albumin in AMN Patients | Biotech Hunter | Biotech Hunter